[Dexamethasone-induced apoptosis of murine MIN6 pancreatic beta-cells and its effect on AKT phosphorylation]
Lin-xi Wang1, Yan-ping Wang, Xiao-ying Liu
1Fujian Endocrinology Institute, Affiliated Union Hospital, Fujian Medical University, Fuzhou 350001, China.
Abstract:
This study is to investigate the effect of dexamethasone on cell apoptosis of murine MIN6 pancreatic beta-cells, and to investigate the mechanism of dexamethasone-dependent cell apoptosis. The cell apoptosis model was established by choosing the murine MIN6 pancreatic beta-cells, which was cultured in vitro and induced by dexamethasone. The morphology of the cell apoptosis was observed through fluorescence microscopic analysis after Hochest/PI staining and flow cytometric assay after Annexin-V/PI staining. The expression of caspase-3 was detected with caspase-3 activity assay kit. The expressions of Cyt-c, Bcl-2, Bax, AKT and p-AKT were observed with Western blotting. The results indicated that after exposure to dexamethasone at a concentration ranging from 50-800 nmol x L(-1) for 48 h, the percentage of cell apoptosis was significantly increased with the concentration over 100 nmol x L(-1) of dexamethasone; after exposure to dexamethasone (100 nmol x L(-1)) for 72 h, the activity of caspase-3 increased significantly; after exposure to dexamethasone at a concentration ranging from 50-800 nmol x L(-1) for 48 h, the expression of Cyt-c increased, Bcl-2 and AKT phosphorylation decreased while Bax and T-AKT remained unchanged. It could be concluded that the effect of dexamethasone on murine MIN6 pancreatic beta-cells apoptosis is significant. The mechanism of dexamethasone-dependent cell apoptosis is probably related to down regulation of the Bcl-2 expression and reduction of AKT phosphorylation.
Insights
Dexamethasone significantly increases apoptosis in murine MIN6 pancreatic beta-cells. This cell death is linked to decreased Bcl-2 expression and reduced AKT phosphorylation, revealing a key mechanism.
Area of Science:
- Cell Biology
- Endocrinology
- Biochemistry
Context:
- Murine MIN6 pancreatic beta-cells are crucial for insulin production.
- Glucocorticoids, like dexamethasone, can impact beta-cell function and survival.
- Understanding dexamethasone's effects on beta-cells is vital for managing metabolic disorders.
Purpose:
- To investigate the impact of dexamethasone on apoptosis in MIN6 pancreatic beta-cells.
- To elucidate the underlying molecular mechanisms of dexamethasone-induced beta-cell apoptosis.
- To quantify changes in key apoptosis-related proteins and signaling pathways.
Summary:
- Dexamethasone treatment significantly elevated apoptosis in MIN6 cells in a dose-dependent manner (above 100 nmol/L).
- Increased caspase-3 activity and cytochrome c release were observed following dexamethasone exposure.
- Downregulation of Bcl-2 expression and decreased AKT phosphorylation were identified as key mechanisms in dexamethasone-induced apoptosis.
Impact:
- Provides critical insights into the cytotoxic effects of dexamethasone on pancreatic beta-cells.
- Identifies specific molecular targets (Bcl-2, AKT pathway) involved in dexamethasone-induced beta-cell apoptosis.
- Contributes to understanding the pathophysiology of beta-cell dysfunction in conditions involving glucocorticoid excess.
